Poker face no more: Cancer recurrence reveals its hand

Christopher J. Chan, Lisa M. Coussens

Research output: Contribution to journalArticle

2 Scopus citations

Abstract

Recurrent disease after apparent ‘cure’ of primary tumors is a common factor that contributes to cancer-associated mortality. A new study suggests that an inflammatory cytokine signature may provide a clinical indication of emergent recurrent disease and, accordingly, may suggest how to select and deliver therapy targeted against the secondary tumor (pages 1625–1631).

Original languageEnglish (US)
Pages (from-to)1569-1570
Number of pages2
JournalNature medicine
Volume19
Issue number12
DOIs
StatePublished - Dec 2013

    Fingerprint

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this